๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The absence of circulating immune complexes in patients with ankylosing spondylitis

โœ Scribed by W. Maksymowych; M. K. Dasgupta; R. S. Rothwell; J. B. Dossetor; A. S. Russell

Publisher
Springer
Year
1981
Tongue
English
Weight
269 KB
Volume
1
Category
Article
ISSN
0172-8172

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Circulating immune complexes in patients
Circulating immune complexes in patients with bone tumours
โœ Amada Segal Eiras; R. A. Robins; R. W. Baldwin; V. S. Byers ๐Ÿ“‚ Article ๐Ÿ“… 1980 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 456 KB

## Abstract Sera from 62 patients with osteogenic sarcoma and 12 with malignant giantโ€cell tumour were tested for the presence of immune complexes by the ^125^Iโ€Clq binding assay. Elevated serum Clq binding activity was found in 67.7% of the osteogenic sarcoma patients and in 75% of the giantโ€cell

Circulating immune complexes in patients
Circulating immune complexes in patients with progressive systemic sclerosis
โœ K. Siminovitch; M. Klein; W. Pruzanski; S. Wilkinson; P. Lee; Sung-Ja Yoon; E. K ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 535 KB

## Abstract Fortyโ€one patients with progressive systemic sclerosis were studied for the presence of immune complexes by the fluidโ€ and solidโ€phase C1q binding, C1 activation, and the fluidโ€phase conglutinin assays. Complement activation and autoantibodies were also studied. Immune complexes were de

Validation exercise of the Ankylosing Sp
Validation exercise of the Ankylosing Spondylitis Assessment Study (ASAS) group response criteria in ankylosing spondylitis patients treated with biologics
โœ Stone, Millicent A. ;Inman, Robert D. ;Wright, James G. ;Maetzel, Andreas ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 96 KB ๐Ÿ‘ 3 views

## Abstract ## Objectives To define what expert clinicians consider a dramatic response in ankylosing spondylitis (AS) patients treated with biologic therapies based on patient and physician assessments of global disease activity. To compare this expert clinicianโ€derived criteria to the Ankylosing